Lyka Labs Ltd Share Price
(LYKALABS)
₹100.41▲0.45%
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1 % |
3 Month Return | -36.51 % |
1 Year Return | -10.71 % |
Market Stats | |
Previous Close | ₹99.96 |
Open | ₹99.85 |
Volume | 2.75L |
Upper Circuit | ₹119.95 |
Lower Circuit | ₹79.96 |
Market Cap | ₹358.36Cr |
P/E Ratio
-47.81
PEG Ratio
55.6
Market Cap
₹358.36 Cr
P/B Ratio
3.88
EPS
-0.79
Dividend Yield
0Sector
Pharmaceuticals
ROE
0Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, -2.13 Cr → 2.71 Cr (in ₹), with an average increase of 100.6% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 72.6%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 41.08% of holdings in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.8% return, outperforming this stock by 154.2%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.15% of holdings in Dec 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 41.18 Cr → 34.62 Cr (in ₹), with an average decrease of 15.9% per quarter
Price Dip
In the last 3 months, LYKALABS stock has moved down by -36.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 58.1% | 0.00 | |
Foreign Institutions | 0.15% | 0.13 | |
Mutual Funds | 0.01% | 0.00 | |
Retail Investors | 41.08% | 0.00 | |
Others | 0.66% | 0.00 |
Lyka Labs in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-47.81x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (23.04x)
September 5, 2022
Lyka Labs Ltd’s net profit jumped 52.25% since last year same period to ₹2.71Cr in the Q3 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 29.05% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹358.36 Cr | 151.64% | 0.69 | -₹3 Cr | ₹111 Cr | |
NA | ₹1,938.35 Cr | 3.13% | 0.52 | NA | NA | |
NA | ₹47.33 Cr | 61.65% | 0.50 | ₹1 Cr | ₹67 Cr | |
NA | ₹1,241.05 Cr | 3.58% | 0.54 | ₹81 Cr | ₹770 Cr | |
NA | ₹294.24 Cr | 146.27% | 1.27 | NA | NA |
Organisation | Lyka Labs |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Lyka Labs Ltd share price today stands at ₹100.41, Open: ₹99.85, Previous Close: ₹99.96, High: ₹104, Low: ₹99, 52 Week High: ₹176.59, 52 Week Low: ₹97.9.
Today's traded volume of Lyka Labs Ltd(LYKALABS) is 2.75L.
Today's market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹358.36Cr.
Lyka Labs Ltd (LYKALABS) share price is ₹100.41. It is down -43.14% from its 52 Week High price of ₹176.59
Lyka Labs Ltd (LYKALABS) share price is ₹100.41. It is up 2.56% from its 52 Week Low price of ₹97.9